Curettage and Electrodessication

On this page

Curettage & Electrodessication - Scoop & Sizzle

  • A destructive technique: curettage ("scoop") removes friable tissue; electrodessication ("sizzle") for hemostasis & residual cell destruction.
  • Indications: Superficial Basal Cell Carcinoma (BCC), Squamous Cell Carcinoma (SCC) in situ (Bowen's disease), seborrheic keratoses, viral warts, pyogenic granulomas.
  • Procedure:
    • Local anesthesia administered.
    • Curette scrapes tumor until firm, normal dermis is felt.
    • Electrodessication applied to the base & margins.
    • Typically 2-3 cycles performed for optimal results.

    ⭐ C&E relies on the textural difference between friable tumor tissue and firm normal dermis for selective removal.

  • Advantages: Rapid, office-based procedure, cost-effective.
  • Disadvantages: Operator-dependent, potential for scarring, no histological margin control. Curettage and Electrodessication Steps

Curettage & Electrodessication - The Zap Kit

  • Instruments: Dermal curette (various sizes), Hyfrecator (electrosurgical unit).
  • Principle: Physical removal by scraping (curettage) followed by electrical desiccation of the lesion base and margins.
  • Indications: Benign (seborrheic keratoses, warts, pyogenic granulomas), Pre-malignant (actinic keratoses), Malignant (superficial basal cell carcinoma, SCC in situ).
  • Technique: Anesthetize → Curette lesion → Electrodessicate base & margins → Repeat 2-3 cycles.
  • Advantages: Quick, cost-effective, good hemostasis.
  • Limitations: Scarring risk, no specimen for complete margin histology.

⭐ Hyfrecators used in electrodessication deliver high-frequency, low-voltage current for coagulation and desiccation, typically in repeated cycles with curettage.

Curettage & Electrodessication - When to Scrape

Curettage and Electrodessication Steps

Indications for Curettage & Electrodessication (C&E): A targeted approach for superficial skin lesions. Not for lesions with deep dermal invasion or high-risk features.

  • Benign Lesions:
    • Seborrheic keratoses
    • Verrucae (warts)
    • Molluscum contagiosum
    • Pyogenic granulomas
    • Acrochordons (skin tags)
  • Pre-Malignant Lesions:
    • Actinic keratoses (especially hypertrophic/resistant)
  • Malignant Lesions (Low-Risk, Well-Defined):
    • Superficial Basal Cell Carcinoma (BCC)
    • Squamous Cell Carcinoma (SCC) in situ (Bowen's disease)
    • Keratoacanthoma (select cases, e.g., small, non-aggressive)

⭐ For superficial Basal Cell Carcinoma (BCC) and Squamous Cell Carcinoma (SCC) in situ (Bowen's disease), C&E is often performed in 2-3 cycles for optimal clearance.

Curettage & Electrodessication - Good & Gnarly

  • Good:
    • Rapid, simple, inexpensive.
    • Achieves good hemostasis.
    • Indications: Benign lesions (e.g., warts, seborrheic keratoses, molluscum contagiosum), superficial BCC/SCC in situ.
  • Gnarly:
    • Potential for scarring, hypopigmentation.
    • 'Blind' technique: no histological margin control.
    • Higher recurrence for aggressive or deep tumors.
    • Avoid in high-risk anatomical sites.

⭐ While C&E is quick and cost-effective, it is a 'blind' procedure with no histological margin control, leading to higher recurrence rates for certain aggressive tumors compared to Mohs surgery or excision.

Curettage & Electrodessication - Red Flags & Recovery

  • Contraindications:
    • ⚠️ Absolute: Suspected melanoma.
    • Lesions needing precise histology (morpheaform BCC, recurrent tumors, H-zone lesions).
    • Patients with pacemakers/ICDs (use bipolar cautery).
    • Significant bleeding disorders.
  • Potential Complications:
    • Scarring (keloids, hypertrophic).
    • Pigmentary changes (hypo/hyper).
    • Infection, bleeding, pain.
    • Recurrence.
  • Recovery & Wound Care:
    • Keep clean, apply ointment, dress.
    • Gentle cleansing after 24-48 hrs.
    • Sun protection vital.
    • Healing: 2-4 weeks. Curettage and electrodessication procedure

⭐ C&E is contraindicated for suspected melanoma and lesions requiring precise histological margin assessment, such as morpheaform BCC, recurrent tumors, or lesions in high-risk areas (e.g., 'H-zone' of the face).

High‑Yield Points - ⚡ Biggest Takeaways

  • C&E is primarily used for superficial, non-aggressive skin cancers like nodular Basal Cell Carcinoma (BCC) and Squamous Cell Carcinoma (SCC) in situ.
  • The procedure involves mechanical scraping with a curette followed by electrodessication for hemostasis and destruction of residual tumor cells.
  • Typically performed in 2-3 cycles to ensure thorough tumor removal and achieve high cure rates.
  • High cure rates (often >90%) are achievable for appropriately selected, low-risk lesions.
  • Contraindicated for aggressive BCC subtypes (e.g., morpheaform), recurrent tumors, or lesions in anatomically challenging or cosmetically sensitive areas.
  • Key advantages include speed, cost-effectiveness, and simplicity; a common disadvantage is scarring and hypopigmentation.
  • It is not ideal for lesions requiring precise margin control or those with deep dermal invasion.

Practice Questions: Curettage and Electrodessication

Test your understanding with these related questions

Sun damage causes malignant transformation of the skin by:

1 of 5

Flashcards: Curettage and Electrodessication

1/10

Augmented TCA (TCA 35% plus Jessner s solution or glycolic acid 70%) is an example of _____ chemical peel

TAP TO REVEAL ANSWER

Augmented TCA (TCA 35% plus Jessner s solution or glycolic acid 70%) is an example of _____ chemical peel

Medium (papillary dermal)

browseSpaceflip

Enjoying this lesson?

Get full access to all lessons, practice questions, and more.

Start Your Free Trial